HSTOQ (Histogen) Other Current Liabilities: $0.79 Mil (As of Sep. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSTOQ Histogen Inc HSTOQ
12 GF Score
Price $0.00
View Full Analysis

What is Histogen Other Current Liabilities?

Histogen HSTOQ +316.67% 12 Other Current Liabilities is $0.79 Mil as of Sep. 2023. GuruFocus rates HSTOQ with a GF Score™ of 12/100.

Histogen's other current liabilities for the quarter that ended in Sep. 2023 was $0.79 Mil.

Histogen's quarterly other current liabilities declined from Mar. 2023 ($0.31 Mil) to Jun. 2023 ($0.14 Mil) but then increased from Jun. 2023 ($0.14 Mil) to Sep. 2023 ($0.79 Mil).

Histogen's annual other current liabilities declined from Dec. 2020 ($0.83 Mil) to Dec. 2021 ($0.35 Mil) and declined from Dec. 2021 ($0.35 Mil) to Dec. 2022 ($0.16 Mil).

Histogen Other Current Liabilities Related Terms

Histogen Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Histogen's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Histogen Other Current Liabilities Chart

Histogen Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Other Current Liabilities
0.18 0.83 0.35 0.16

Histogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.15 0.16 0.31 0.14 0.79
HSTOQ
12GF Score
Histogen Inc HSTOQ
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Histogen Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of $0.79 Mil mean?
Histogen (HSTOQ) has a Other Current Liabilities of $0.79 Mil as of Sep. 2023. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Histogen.
Is Histogen's Other Current Liabilities too high?
Histogen's current Other Current Liabilities is $0.79 Mil. Overall, Histogen has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Histogen's Other Current Liabilities compare to GLMD and BLCM?
Histogen's Other Current Liabilities of $0.79 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Histogen. Histogen's current Other Current Liabilities is $0.79 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Histogen stock overvalued right now?
Histogen (HSTOQ) has a current Other Current Liabilities of $0.79 Mil. The current Other Current Liabilities is $0.79 Mil. Histogen's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Histogen (HSTOQ), the current Other Current Liabilities is $0.79 Mil as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Histogen Business Description

Address 10655 Sorrento Valley Road, Suite 200, San Diego, CA, USA, 92121
Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Under its biologics technology platform, the product candidates in development are HST-003, a treatment for joint cartilage repair, and HST-004, a treatment for spinal disc repair. It also has a pipeline of clinical and preclinical small molecule pan-caspase and caspase selective inhibitors focused on treatments for infectious and inflammatory diseases that the company intends to develop.
12GF Score

Get the complete analysis for HSTOQ

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price